{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-278012","form_type":"8-K/A","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2023-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.470597+00:00","generated_at":"2026-06-08T02:03:10.923091+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Globus Medical files pro forma financials for NuVasive Merger; combined net income $6M for 9 months","bullets":["Pro forma net income for nine months ended Sep 30, 2023: $6.0M ($0.04 diluted EPS) vs Globus standalone $107.8M.","Total purchase price $2.6B; goodwill $924M, intangible assets $1.22B (developed tech, customer relationships).","Pro forma net income for FY2022: $5.2M ($0.04 diluted EPS) vs Globus standalone $190.2M.","NuVasive contributed $827M revenue for Jan–Aug 2023; inventory step-up of $284M added to cost of sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-278012","json":"https://secwatch.observer/filing/0001193125-23-278012.json","markdown":"https://secwatch.observer/filing/0001193125-23-278012.md","text":"https://secwatch.observer/filing/0001193125-23-278012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523278012/0001193125-23-278012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523278012/d315801d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T02:03:10.923091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}